Page last updated: 2024-08-26

lopinavir and HIV

lopinavir has been researched along with HIV in 76 studies

*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	33 (43.42)	29.6817
2010's	34 (44.74)	24.3611
2020's	9 (11.84)	2.80

Authors

Authors	Studies
Betebenner, DA; Herrin, T; Kempf, DJ; Kumar, G; Molla, A; Norbeck, DW; Plattner, JJ; Saldivar, A; Sham, HL; Vasavanonda, S	1
Brieger, M; Furfine, ES; Hazen, RJ; Kaldor, I; Miller, JF; Reynolds, D; Sherrill, RG; Spaltenstein, A	1
Arvidsson, PI; Govender, P; Govender, T; Honarparvar, B; Kruger, HG; Maguire, GE; Makatini, MM; Petzold, K; Sayed, Y; Soliman, ME; Sriharsha, SN	1
Aidara, M; Alleyo, A; Diallo, K; Manga, NM; Wembulua, BS	1
Jacobs, BA; Mtshali, S	1
Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA	1
Aarnoutse, R; Chabala, C; Cotton, MF; Denti, P; Galileya, LT; Gibb, D; Hesseling, A; Lee, J; McIlleron, H; Njahira Mukui, I; Rabie, H; Turkova, A; Wasmann, RE; Zar, H	1
George, PE; Mercedes, R; Nabukeera-Barungi, N; Otto, SBJ	1
Cao, Y; Xu, S; Zhou, M; Zhu, F	1
Alonso-Castro, AJ; Alvarez-Alvarez, RM; Del Carmen Preciado-Puga, M; Del Rocio Ibarra-Reynoso, L; Lazo-de-la-Vega-Monroy, ML; Ruiz-Noa, Y; Ruiz-Padilla, AJ; Sánchez-Barajas, M	1
Agolory, S; Bikinesi, L; Carmona, S; Dean, N; Fisher-Walker, CL; Hamunime, N; Hong, SY; Hunter, CJ; Jordan, MR; Kana, V; Mutenda, N; Negussie, T; Parkin, N; Raizes, EG; Sawadogo, S; Shiningavamwe, AN; Steegen, K; Tang, AM; Yang, C	1
Benson, CA; Cardoso, SW; Fletcher, CV; Ive, P; Kendall, MA; Lalloo, U; Podany, AT; Wu, X	1
Cassim, H; Gray, GE; Greeff, OBW; Lazarus, E; Liberty, A; Otwombe, K; Violari, A	1
Achan, J; Bangirana, P; Banik, A; Boivin, MJ; Giron, LB; Pillai, SK; Ruel, TD; Sikorskii, A	1
de Mast, Q; Kinabo, GD; Mchaile, DN; Schellekens, AFA; Van de Wijer, L; van der Ven, AJAM	1
Abrams, EJ; Coovadia, A; Hunt, G; Kuhn, L; Mbete, N; Murnane, PM; Patel, F; Shiau, S; Strehlau, R	1
Hill, AM; Venter, F	1
de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J	1
Tartaglia, A	1
Dalal, V; Murthy, AN; Ravi, PR; Vats, R	1
Fairlie, L; Meyers, T; Moultrie, H; Pinillos, F; Sawry, S; van Zyl, G; Wong, JY	1
Ajose, O; Beanland, RL; Calmy, A; Doherty, M; Ford, N; Irvine, C; Mayer, KH; Rapparini, C; Shubber, Z; Vitoria, M	1
Cai, W; Caughey, B; Chung, C; Dai, Z; Hu, F; Lan, Y; Li, L; Tang, X; Zhang, K	1
Andreoni, M; Antinori, A; Castagna, A; Ceccherini-Silberstein, F; Celesia, BM; Cozzi-Lepri, A; d'Arminio Monforte, A; De Luca, A; Galli, M; Gianotti, N; Mussini, C; Pinnetti, C; Spagnuolo, V	1
Boulle, A; Cohen, K; Davies, MA; de Waal, R; Fortuin-de Smidt, M; Igumbor, EU; Maartens, G; Stinson, K; Technau, KG	1
Ananworanich, J; Boonrak, P; Bunupuradah, T; Burger, D; Engchanil, C; Intasan, J; Kosalaraksa, P; Lumbiganon, P; Ruxrungtham, K; Schutz, M	1
Cohen, C; De Luca, A; Grant, P; Harrington, R; Hawkins, T; Kempf, D; Nadler, J; Rode, R; Shafer, R; Wong, EC; Zolopa, A	1
Curran, A; Ribera Pascuet, E	1
García Deltoro, M	1
Arranz Caso, JA	1
López Aldeguer, J	1
Bierman, WF; Boucher, CA; de Jong, D; Fun, A; Jaspers, CA; Kagan, R; Nijhuis, M; Schurink, KA; van Agtmael, MA; Wensing, AM	1
Aberg, J; Andrade, A; Dehlinger, M; Eshleman, SH; Ferguson, E; Flexner, C; Gross, R; Kashuba, A; Kmack, A; Lalama, C; Mildvan, D; Parsons, T; Rosenkranz, SL; Sanne, I; Tierney, C	1
Abrams, EJ; Coovadia, A; Ko, S; Kuhn, L; Meyers, T; Reitz, C; Sherman, G; Strehlau, R	1
Calza, L; Colangeli, V; Erario, A; Grossi, G; Manfredi, R; Mosca, L; Piergentili, B; Pocaterra, D; Verucchi, G; Viale, P	1
Dhlomo, S; Emery, S; Grandits, G; Khabo, P; Khanyile, T; Komati, S; Magongoa, D; Naidoo, LC; Neaton, JD; Polis, M; Qolohle, D; Ratsela, A	1
Bruce-Keller, AJ; Domingue, M; Gupta, S; Ingram, DK; Keller, JN; Kheterpal, I; Knight, AG; Pistell, PJ; Ruiz, C; Uranga, RM	1
Doroshyenko, O; Fätkenheuer, G; Frank, D; Fuhr, U; Hein, W; Jetter, A; Kirchheiner, J; Klaassen, T; Schömig, E; Seeringer, A; Wyen, C	1
Acosta, EP; Easley, KA; Eaton, ME; Lennox, JL; Long, MC; Masalovich, SE; Ofotokun, I; Ritchie, JC	1
Dewar, RL; Dlamini, JN; Follmann, DA; Highbarger, HC; Hu, Z; Pau, AK; Somaroo, H	1
Cotton, M; Eley, B; Fairlie, L; Maartens, G; McIlleron, H; Merry, C; Meyers, T; Nuttall, J; Rabie, H; Ren, Y; Smith, PJ	1
Kuhn, L; Meyers, TM; Moultrie, H; Yotebieng, M	1
Cozzi-Lepri, A; Dunn, D; Kjær, J; Lundgren, JD; Paredes, R; Phillips, AN; Pillay, D; Prosperi, MC; Sabin, CA	1
Bergin, C; Hennessy, M; Hopkins, S; Kennedy, A; Mulcahy, F; Spiers, JP	1
Allan, S; Back, D; Fidler, S; Fisher, M; Gilleran, G; Heald, L; Jayasuriya, A; Owen, A; Smit, E; Taylor, S; Wilkins, E	1
Asboe, D; Bansi, L; Barber, TJ; Dunn, D; Gilson, R; Harrison, L; Kirk, S; Pillay, D; Williams, I	1
Clotet, B; Domingo, P; Galindo, MJ; Imaz, A; Iribarren, JA; Llibre, JM; Mariño, A; Miralles, C; Moreno, S; Ornelas, A; Santos, JR; Schapiro, JM	1
Dunn, DT; Gibb, DM; Gilks, CF; Kaleebu, P; Kasirye, R; Kikaire, B; Mambule, I; Musana, H; Pillay, D; Reid, A; Robertson, V; Spyer, M; Ssali, F; Walker, AS; Yirrell, D	1
Abel, F; Behrens, G; Domingo, P; Maserati, R; Pearce, G; Rieger, A; Wang, H	1
Ananworanich, J; Bhakeecheep, S; Bowonwatanuwong, C; Bunupuradah, T; Chetchotisakd, P; Hirschel, B; Jirajariyavej, S; Kantipong, P; Kerr, SJ; Klinbuayaem, V; Munsakul, W; Prasithsirikul, W; Ruxrungtham, K; Sophonphan, J; Sungkanuparph, S	1
Ananworanich, J; Bunupuradah, T; Chobkarjing, U; Chuanjaroen, T; Kosalaraksa, P; Lumbiganon, P; Pancharoen, C; Phanuphak, P; Pinyakorn, S; Puthanakit, T	1
Bierhoff, M; Boucher, CA; Fibriani, A; Ten Kate, RW	1
Bernstein, B; Brun, SC; Isaacson, JD; Kempf, DJ; King, MS; Richards, B; Rode, R; Sun, E; Sylte, J	1
Korn, K; Moschik, G; Paatz, C; Schmidt, B; Schnell, T; Thein, C; Walter, H	1
Arroyo, JA; Baldovi, F; de Lazzari, E; Domingo, P; Galindo, MJ; Gatell, JM; Larrousse, M; León, A; Martínez, E; Milinkovic, A	1
Boeri, E; Castagna, A; Danise, A; Gianotti, N; Hasson, H; Lazzarin, A; Nozza, S; Seminari, E	1
DeGoey, DA; Randolph, JT	1
Badri, S; Conover, CS; Jacobson, LP; Li, X; Margolick, JB; Riddler, SA; Witt, MD	1
Adler, E; Cohen, C; Fessel, WJ; Gladysz, A; Gonzalez-Garcia, J; McGovern, R; McLaren, C; Nieto-Cisneros, L; Zala, C	1
Jäger, H; Theobald, T	1
Antoniadou, A; Giamarellou, H; Katsarolis, I; Panagopoulos, P; Papadopoulos, A; Poulakou, G; Tsiodras, S	1
Chan-Tack, KM; Edozien, A	1
Hussain, S; Khayat, A; Rathore, MH; Tolaymat, A	1
Hansen, AB; Justesen, US; Mathiesen, S; Von Lüttichau, HR	1
Babacan, E; Carlebach, A; Dauer, B; Gute, P; Haberl, A; Hermschulte, Y; Klauke, S; Staszewski, S; Stephan, C; Stuermer, M	1
Boyle, BA; Cohen, CJ; Elion, R; Frank, I; Moyle, GJ; Sax, PE	1
Allavena, C; Brunet-François, C; Chêne, G; Cuzin, L; Dellamonica, P; Le Moing, V; Lewden, C; Masquelier, B; Raffi, F; Spire, B; Taieb, A	1
Agarwal, R; Considine, RV; Dubé, MP; Gupta, SK; Mather, KJ; Saha, CK	1
Abbara, C; Barrail, A; Boissonnas, A; Bonhomme-Faivre, L; Duclos-Vallée, JC; Samuel, D; Taburet, AM; Teicher, E; Vincent, I; Vittecoq, D	1
Egbers, C; Eley, BS; Maartens, G; McIlleron, HM; Meyers, TM; Nuttall, JJ; Ren, Y; Smith, PJ	1
Arranz, A; Arribas, JR; Delgado, R; González-García, J; Hernando, A; Miralles, P; Pérez-Valero, I; Pulido, F	1
Geretti, AM	1
Mascolini, M	1
Han, L; Hsu, A; Kempf, DJ; Lin, CT; Mo, H; Molla, A; Vasavanonda, S	1

Reviews

7 review(s) available for lopinavir and HIV

Article	Year
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus. The Cochrane database of systematic reviews, 2023, 06-12, Volume: 6 Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine	2023
Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jun-01, Volume: 60 Suppl 3 Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Emtricitabine; HIV; HIV Infections; Humans; Lopinavir; Post-Exposure Prophylaxis; Ritonavir; Tenofovir; World Health Organization	2015
[Resistance to darunavir]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 10 Topics: Adult; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Darunavir; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Lopinavir; Male; Multicenter Studies as Topic; Mutagenesis, Site-Directed; Mutation, Missense; Nitriles; Phenotype; Point Mutation; Pyridazines; Pyrimidines; Pyrimidinones; Randomized Controlled Trials as Topic; Sulfonamides	2008
[Monotherapy in treatment-naïve patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 16 Topics: Clinical Trials as Topic; Cost-Benefit Analysis; Drug Combinations; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Treatment Outcome; Viral Load; Virus Replication	2008
[Lopinavir/ritonavir monotherapy. Possible indications]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 16 Topics: Clinical Trials as Topic; Cost-Benefit Analysis; Drug Combinations; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Mitochondria; Pyrimidinones; Randomized Controlled Trials as Topic; Ritonavir; Treatment Outcome; Viral Load; Virus Replication	2008
Peptidomimetic inhibitors of HIV protease. Current topics in medicinal chemistry, 2004, Volume: 4, Issue:10 Topics: Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; Dipeptides; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Models, Molecular; Molecular Mimicry; Molecular Structure; Nelfinavir; Oligopeptides; Organophosphates; Peptides; Phenylbutyrates; Pyridines; Pyrimidinones; Ritonavir; Saquinavir; Sulfonamides; Urethane	2004
Resistance testing methodologies and mechanisms of resistance. Journal of HIV therapy, 2007, Volume: 12, Issue:4 Topics: Adenine; Anti-HIV Agents; CCR5 Receptor Antagonists; Drug Resistance, Viral; HIV; Humans; Lopinavir; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Pyrimidinones; Tenofovir	2007

Trials

16 trial(s) available for lopinavir and HIV

Article	Year
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 08-16, Volume: 73, Issue:4 Topics: Adult; Anti-HIV Agents; Coinfection; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Rifabutin; Rifampin; Ritonavir; Tuberculosis	2021
Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy. Journal of the International AIDS Society, 2017, Volume: 20, Issue:2 Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV; HIV Infections; Humans; Leukocytes, Mononuclear; Lopinavir; Male; Neurocognitive Disorders; Reverse Transcriptase Inhibitors; Uganda	2017
Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:7 Topics: Anti-HIV Agents; Blood Chemical Analysis; CD4 Lymphocyte Count; Child; Cholesterol; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Prospective Studies; Pyrimidinones; Ritonavir; Saquinavir; Thailand; Treatment Refusal; Triglycerides; Viral Load	2008
[Darunavir as first-line therapy. The TITAN study]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 10 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Darunavir; Diarrhea; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lopinavir; Male; Prognosis; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Salvage Therapy; Sulfonamides	2008
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Apr-01, Volume: 50, Issue:7 Topics: Anti-Retroviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Lopinavir; Male; Proportional Hazards Models; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load	2010
Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. The Journal of infectious diseases, 2010, Apr-15, Volume: 201, Issue:8 Topics: Antiretroviral Therapy, Highly Active; Antitubercular Agents; Child, Preschool; Drug Therapy, Combination; Ethionamide; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Isoniazid; Kaplan-Meier Estimate; Lopinavir; Male; Pyrimidinones; Rifampin; Ritonavir; RNA, Viral; South Africa; Tuberculosis, Pulmonary; Viral Load	2010
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa. The Journal of infectious diseases, 2010, Nov-15, Volume: 202, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; RNA, Viral; South Africa; Stavudine; Treatment Outcome; Zidovudine	2010
Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure. Journal of clinical pharmacology, 2011, Volume: 51, Issue:11 Topics: Adult; Anti-HIV Agents; Area Under Curve; CD4-Positive T-Lymphocytes; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Orosomucoid; Prospective Studies; Protein Binding; Ritonavir; RNA, Viral	2011
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). Antiviral therapy, 2012, Volume: 17, Issue:7 Topics: Adult; Africa; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Mutation; Ritonavir; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Viremia	2012
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles. Antiviral therapy, 2012, Volume: 17, Issue:6 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Drug Substitution; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV; HIV Infections; Humans; Lamivudine; Lipids; Lopinavir; Male; Medication Adherence; Middle Aged; Organophosphorus Compounds; Ritonavir; Treatment Outcome	2012
A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Antiviral therapy, 2012, Volume: 17, Issue:7 Topics: Adenine; Adult; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Organophosphonates; Ritonavir; Tenofovir	2012
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy. Antiviral therapy, 2002, Volume: 7, Issue:3 Topics: Drug Resistance, Viral; Drug Therapy, Combination; Genes, Viral; Genotype; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Inhibitory Concentration 50; Logistic Models; Lopinavir; Mutation; Phenotype; Pyrimidinones; Ritonavir; RNA, Viral; Time Factors; Viral Load	2002
Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial. Current medical research and opinion, 2005, Volume: 21, Issue:10 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Cholesterol; Cholesterol, LDL; Female; HIV; HIV Infections; Humans; Lopinavir; Male; Oligopeptides; Protease Inhibitors; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Triglycerides	2005
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5 Topics: Adult; Aged; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Drug Interactions; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Salvage Therapy; Saquinavir; Viral Load	2006
Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study. Clinical pharmacokinetics, 2007, Volume: 46, Issue:11 Topics: Adult; Aged; Alkynes; Antiretroviral Therapy, Highly Active; Area Under Curve; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dose-Response Relationship, Drug; Female; Graft Rejection; Half-Life; Hepatitis C; HIV; HIV Infections; Humans; Liver Transplantation; Lopinavir; Male; Middle Aged; Nelfinavir; Pyrimidinones; Ritonavir; Tacrolimus; Viral Load	2007
Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression. The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6 Topics: Adult; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Longitudinal Studies; Lopinavir; Male; Mutation; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load	2008

Other Studies

53 other study(ies) available for lopinavir and HIV

Article	Year
Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Bioorganic & medicinal chemistry letters, 2001, Jun-04, Volume: 11, Issue:11 Topics: Anti-HIV Agents; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; HIV; HIV Protease Inhibitors; Humans; Lopinavir; Microbial Sensitivity Tests; Mixed Function Oxygenases; Pyrimidinones	2001
Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles. Bioorganic & medicinal chemistry letters, 2005, Aug-01, Volume: 15, Issue:15 Topics: Animals; Anti-HIV Agents; Dogs; Drug Resistance, Multiple, Viral; HIV; HIV Protease Inhibitors; Inhibitory Concentration 50; Mutation; Rats; Structure-Activity Relationship; Virus Replication	2005
Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease. Bioorganic & medicinal chemistry letters, 2011, Apr-15, Volume: 21, Issue:8 Topics: Alkanes; Binding Sites; Catalytic Domain; Computer Simulation; Genotype; HIV; HIV Protease; HIV Protease Inhibitors; Humans; South Africa	2011
Osteonecrosis of the humeral head in a human immunodeficiency virus-infected patient under tenofovir disoproxil fumarate-emtricitabine-lopinavir/ritonavir for 10 years: a case report. Journal of medical case reports, 2021, Dec-18, Volume: 15, Issue:1 Topics: Emtricitabine; Female; HIV; HIV Infections; Humans; Humeral Head; Lopinavir; Middle Aged; Osteonecrosis; Ritonavir; Tenofovir	2021
A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Anti-Retroviral Agents; HIV; HIV Infections; Humans; Latent Tuberculosis; Lopinavir; Models, Biological; Rifampin; Ritonavir; Tuberculosis	2022
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. PLoS medicine, 2023, Volume: 20, Issue:11 Topics: Adolescent; Adult; Antitubercular Agents; Child; Child, Preschool; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Lopinavir; Male; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis	2023
Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report. BMC infectious diseases, 2020, Jan-21, Volume: 20, Issue:1 Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Benzoxazines; Child; Cryptococcus neoformans; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Female; Fluconazole; HIV; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Lopinavir; Meningitis, Cryptococcal; Ritonavir; Treatment Outcome; Viral Load; Zidovudine	2020
Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. Journal of medical virology, 2020, Volume: 92, Issue:6 Topics: Anti-HIV Agents; Betacoronavirus; China; Clinical Laboratory Techniques; Coinfection; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Mellitus, Type 2; Drug Combinations; gamma-Globulins; HIV; HIV Infections; Humans; Lopinavir; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome	2020
FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment. Current HIV research, 2020, Volume: 18, Issue:5 Topics: Adult; Anti-Retroviral Agents; Atherosclerosis; Female; Fibroblast Growth Factors; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Inflammation; Inflammation Mediators; Lipid Metabolism; Lopinavir; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Risk Factors; Ritonavir; Tenofovir; Young Adult	2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia. Medicine, 2020, Sep-11, Volume: 99, Issue:37 Topics: Adolescent; Adult; Anti-HIV Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Lopinavir; Male; Middle Aged; Namibia; Prevalence; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Failure; Young Adult	2020
A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa. PloS one, 2017, Volume: 12, Issue:7 Topics: Child, Preschool; Dideoxynucleosides; Drug Combinations; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Lopinavir; Male; Retrospective Studies; Ritonavir; South Africa; Stavudine; Treatment Outcome; Viral Load	2017
Safety Evaluation of Efavirenz in Children: Don't Forget the Central Nervous System. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 03-19, Volume: 66, Issue:7 Topics: Alkynes; Benzoxazines; Child; Cyclopropanes; HIV; Humans; Lopinavir; Nervous System; Nevirapine; Ritonavir	2018
Reply to Van de Wijer et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 03-19, Volume: 66, Issue:7 Topics: Alkynes; Benzoxazines; Child; Cyclopropanes; HIV; Humans; Lopinavir; Nevirapine; Ritonavir	2018
The unexpected success of NRTIs in second-line treatment. The Lancet. Infectious diseases, 2018, Volume: 18, Issue:1 Topics: Anti-HIV Agents; DNA-Directed RNA Polymerases; Follow-Up Studies; HIV; Lopinavir; Raltegravir Potassium; Reverse Transcriptase Inhibitors	2018
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethambutol; Female; HIV; HIV Infections; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
Multidrug nanosuspensions: future perspectives on drug delivery system for HIV combination antiretroviral therapy. AIDS (London, England), 2018, 11-13, Volume: 32, Issue:17 Topics: Alkynes; Animals; Benzoxazines; Cyclopropanes; Drug Delivery Systems; HIV; HIV Infections; Lopinavir; Primates; Tenofovir	2018
A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation. The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:7 Topics: Animals; Delayed-Action Preparations; Drug Combinations; Drug Delivery Systems; Drug Stability; Endocytosis; HIV; HIV Protease Inhibitors; Humans; Intestinal Absorption; Lipids; Lopinavir; Male; Nanoparticles; Rats, Wistar; Ritonavir; Stearic Acids; Tissue Distribution	2014
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. The Pediatric infectious disease journal, 2015, Volume: 34, Issue:2 Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Child, Preschool; Cohort Studies; Drug Resistance, Viral; Female; Genotype; HIV; HIV Infections; Humans; Infant; Lopinavir; Male; Mutation, Missense; Ritonavir; South Africa; Treatment Failure; Viral Load	2015
Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART). Current molecular medicine, 2015, Volume: 15, Issue:10 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; Case-Control Studies; Cyclopropanes; DNA, Mitochondrial; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Lopinavir; Male; Middle Aged; Mitochondria; Nelfinavir; Predictive Value of Tests; Ritonavir; ROC Curve; Stavudine; Zidovudine	2015
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. PloS one, 2017, Volume: 12, Issue:2 Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kaplan-Meier Estimate; Lopinavir; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Ritonavir; RNA, Viral; Viral Load; Viremia; Young Adult	2017
First-line antiretroviral drug discontinuations in children. PloS one, 2017, Volume: 12, Issue:2 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Follow-Up Studies; HIV; HIV Infections; Humans; Infant; Kaplan-Meier Estimate; Lopinavir; Outcome Assessment, Health Care; Proportional Hazards Models; Ritonavir; South Africa; Stavudine; Withholding Treatment; Zidovudine	2017
Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Adolescent; Adult; Aged; Cohort Studies; Drug Resistance, Viral; Female; Genes, Viral; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Mutation; Pyrimidinones; Retrospective Studies; Ritonavir; Young Adult	2008
Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects. Project Inform perspective, 2009, Issue:48 Topics: CD4 Lymphocyte Count; HIV; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Pyrrolidinones; Raltegravir Potassium; Viral Load	2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V. The Journal of infectious diseases, 2009, Sep-01, Volume: 200, Issue:5 Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; DNA Mutational Analysis; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; HIV; HIV Infections; HIV Protease; Humans; Longitudinal Studies; Lopinavir; Molecular Sequence Data; Mutation, Missense; Phylogeny; Pyrimidinones; Ritonavir; Sequence Analysis, DNA; Sequence Homology; Treatment Failure; Virus Replication	2009
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. European journal of clinical pharmacology, 2011, Volume: 67, Issue:2 Topics: Adult; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Viral Load	2011
Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice. Antiviral research, 2010, Volume: 88, Issue:3 Topics: Animals; Cognition; Drug Administration Schedule; Drug Combinations; HIV; HIV Infections; HIV Protease Inhibitors; Lopinavir; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Motor Activity; Pyrimidinones; Ritonavir; Weight Loss	2010
Do activities of cytochrome P450 (CYP)3A, CYP2D6 and P-glycoprotein differ between healthy volunteers and HIV-infected patients? Antiviral therapy, 2010, Volume: 15, Issue:7 Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Dextromethorphan; Digoxin; Down-Regulation; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Midazolam; Middle Aged; Pyrimidinones; Ritonavir; Young Adult	2010
Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir. Pharmacotherapy, 2011, Volume: 31, Issue:2 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Trials, Phase II as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lopinavir; Nevirapine; Pyrimidinones; Randomized Controlled Trials as Topic; Retrospective Studies; Ritonavir; RNA, Viral; South Africa; Young Adult	2011
Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antiviral therapy, 2011, Volume: 16, Issue:3 Topics: Anti-HIV Agents; Antitubercular Agents; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infant; Lopinavir; Male; Pyrimidinones; Rifampin; Ritonavir; South Africa; Treatment Outcome; Tuberculosis	2011
Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa. The Pediatric infectious disease journal, 2011, Volume: 30, Issue:11 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Coinfection; Cyclopropanes; Female; Follow-Up Studies; HIV; HIV Infections; Hospitals, Public; Humans; Infant; Lopinavir; Male; Mycobacterium tuberculosis; Recurrence; Ritonavir; South Africa; Survival Analysis; Tuberculosis, Pulmonary; Viral Load	2011
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score. PloS one, 2011, Volume: 6, Issue:11 Topics: Cohort Studies; Data Interpretation, Statistical; Drug Resistance, Viral; Genotype; Health Personnel; HIV; HIV Infections; Humans; Internet; Linear Models; Lopinavir; Mutation	2011
Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients. Antiviral therapy, 2011, Volume: 16, Issue:8 Topics: Adult; Antiviral Agents; Cell Line; Cohort Studies; Coinfection; Female; Hepacivirus; Hepatic Stellate Cells; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Ireland; Lopinavir; Male; Monocytes; Recombinant Proteins; Ribavirin; RNA, Viral; Saquinavir; Tissue Inhibitor of Metalloproteinase-2; United Kingdom; Viral Load	2011
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV; HIV Infections; Humans; Lopinavir; Male; Middle Aged; Plasma; Ritonavir; Time Factors; Treatment Outcome; Viral Load	2012
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Ritonavir; RNA, Viral; Selection, Genetic; Sequence Analysis, DNA; Treatment Failure; United Kingdom; Young Adult	2012
Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Adult; Amino Acid Substitution; Anti-HIV Agents; Cohort Studies; Female; HIV; HIV Infections; HIV Protease; Humans; Lopinavir; Male; Mutation, Missense; Retrospective Studies; Ritonavir; Treatment Failure; United States	2012
Long-term lopinavir/ritonavir monotherapy in HIV-infected children. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:4 Topics: Adolescent; Anti-HIV Agents; Child; Female; HIV; HIV Infections; Humans; Lopinavir; Male; Ritonavir; Time Factors; Treatment Outcome; Viral Load	2013
Ongoing HIV replication in cerebrospinal fluid under successful monotherapy. Antiviral therapy, 2013, Volume: 18, Issue:4 Topics: Drug Resistance, Viral; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Mutation; Ritonavir; RNA, Viral; Sequence Analysis, RNA; Viral Load; Virus Replication	2013
Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples. AIDS (London, England), 2003, May-23, Volume: 17, Issue:8 Topics: Atazanavir Sulfate; Carbamates; Drug Resistance, Multiple, Viral; Furans; HIV; HIV Protease Inhibitors; Humans; Lopinavir; Oligopeptides; Pyridines; Pyrimidinones; Retrospective Studies; Sulfonamides	2003
Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Apr-01, Volume: 38, Issue:7 Topics: Adult; Antiretroviral Therapy, Highly Active; Cholesterol; Cholesterol, HDL; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Metabolic Diseases; Pyrimidinones; Risk Factors; Ritonavir; Triglycerides	2004
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients. AIDS (London, England), 2004, Jan-02, Volume: 18, Issue:1 Topics: Adult; Anti-Retroviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Viral; Drug Therapy, Combination; Female; Furans; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Mutation; Pyrimidinones; Retrospective Studies; Ritonavir; RNA, Viral; Sulfonamides	2004
Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. Journal of acquired immune deficiency syndromes (1999), 2005, Mar-01, Volume: 38, Issue:3 Topics: Adult; Age Factors; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Depression; Dideoxynucleosides; Ethnicity; HIV; HIV Infections; Humans; Logistic Models; Lopinavir; Male; Middle Aged; Pyrimidinones; Risk Factors; RNA, Viral; Treatment Refusal	2005
[First-line monotherapy with boostered protease inhibitor. Effectively reduce viral load with only one drug?]. MMW Fortschritte der Medizin, 2005, Apr-25, Volume: 147 Spec No 1 Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Early Diagnosis; HIV; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Pyrimidinones; Treatment Outcome; Viral Load	2005
Efficacy and safety of an anti-retroviral combination regimen including either efavirenz or lopinavir-ritonavir with a backbone of two nucleoside reverse transcriptase inhibitors. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:5 Topics: Adult; Aged; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Male; Middle Aged; Oxazines; Pyrimidinones; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Triglycerides; Viral Load	2006
Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression. Journal of acquired immune deficiency syndromes (1999), 2006, Apr-01, Volume: 41, Issue:4 Topics: Anti-HIV Agents; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir; Viral Load	2006
Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir. Pediatric nephrology (Berlin, Germany), 2006, Volume: 21, Issue:7 Topics: Adenine; Anti-HIV Agents; Child; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Kidney Diseases; Lopinavir; Organophosphonates; Pregnancy; Pregnancy Complications; Pyrimidinones; Ritonavir; Tenofovir	2006
Genotyping of CYP2B6 and therapeutic drug monitoring in an HIV-infected patient with high efavirenz plasma concentrations and severe CNS side-effects. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:8 Topics: Adult; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Monitoring; Genotype; HIV; HIV Infections; Humans; Lopinavir; Male; Oxazines; Oxidoreductases, N-Demethylating; Pyrimidinones	2006
XVI International AIDS Conference: Part 2. The AIDS reader, 2006, Volume: 16, Issue:11 Topics: Acquired Immunodeficiency Syndrome; CCR5 Receptor Antagonists; Clinical Trials as Topic; Darunavir; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Organic Chemicals; Pyrimidinones; Pyrrolidinones; Raltegravir Potassium; Receptors, CCR5; Ritonavir; Salvage Therapy; Sulfonamides	2006
[Lopinavir/ritonavir in HIV-infected patient with long-term virological failure: immunovirological response and tolerance in 121 patients of the ANRS CO8 Aproco-Copilote cohort]. Medecine et maladies infectieuses, 2007, Volume: 37, Issue:3 Topics: Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Drug Tolerance; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Pilot Projects; Pyrimidinones; Ritonavir; Treatment Failure	2007
Proteinuria and endothelial dysfunction in stable HIV-infected patients. A pilot study. Journal of acquired immune deficiency syndromes (1999), 2007, Aug-15, Volume: 45, Issue:5 Topics: Adult; Aged; Cross-Sectional Studies; Endothelium, Vascular; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Male; Nitroglycerin; Pilot Projects; Proteinuria; Pyrimidinones; Regional Blood Flow; Ritonavir; Vasodilation	2007
Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis. Journal of acquired immune deficiency syndromes (1999), 2008, Apr-15, Volume: 47, Issue:5 Topics: Antibiotics, Antitubercular; Child, Preschool; Drug Interactions; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Male; Pyrimidinones; Rifampin; Ritonavir; Tuberculosis	2008
ICAAC eyes PIs, NNRTIs, and STIs. IAPAC monthly, 2000, Volume: 6, Issue:12 Topics: Animals; Anti-HIV Agents; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Drugs, Investigational; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Mutation; Ontario; Pyrimidinones; Reverse Transcriptase Inhibitors; Viral Load	2000
[No resistance even after 1 year. New drug combination against HIV]. MMW Fortschritte der Medizin, 2001, Apr-02, Volume: 143 Suppl 1 Topics: Drug Combinations; Drug Resistance, Microbial; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir; Treatment Outcome	2001
In vitro antiviral interaction of lopinavir with other protease inhibitors. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7 Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Lopinavir; Microbial Sensitivity Tests; Pyrimidinones	2002